Swissmedic approves IFINWIL® (eflornithine) for children diagnosed with high-risk neuroblastoma (...

Swissmedic approves IFINWIL® (eflornithine) for children diagnosed with high-risk neuroblastoma (HRNB)  PR Newswire

Swissmedic approves Novartis’ malaria medicine for babies - Pharmaceutical Technology

Swissmedic approves Novartis’ malaria medicine for babies  Pharmaceutical Technology

Euro Roundup: Swissmedic pilots fast-track procedure to accelerate clinical trial authorizations ...

Euro Roundup: Swissmedic pilots fast-track procedure to accelerate clinical trial authorizations  Regulatory Affairs Professionals Society | RAPS

Novartis receives approval for first malaria medicine for newborn babies and young infants - Nova...

Novartis receives approval for first malaria medicine for newborn babies and young infants  Novartis

Swissmedic approves first malaria treatment for infants - drugdiscoverytrends.com

Swissmedic approves first malaria treatment for infants  drugdiscoverytrends.com

Regulatory Recap: Swissmedic Reduces Review Times For Generics By Six Months - insights.citeline.com

Regulatory Recap: Swissmedic Reduces Review Times For Generics By Six Months  insights.citeline.com

CARBOGEN AMCIS passes Swissmedic inspection - European Pharmaceutical Manufacturer

CARBOGEN AMCIS passes Swissmedic inspection  European Pharmaceutical Manufacturer

Swissmedic approves IFINWIL for children with high-risk neuroblastoma - Pharmaceutical Technology

Swissmedic approves IFINWIL for children with high-risk neuroblastoma  Pharmaceutical Technology

Swissmedic reinforces Switzerland’s role in global regulatory collaboration and advanced therapeu...

Swissmedic reinforces Switzerland’s role in global regulatory collaboration and advanced therapeutics  Greater Geneva Bern area

Euro Roundup: Swissmedic mandates nitrosamine risk assessments in some applications - Regulatory ...

Euro Roundup: Swissmedic mandates nitrosamine risk assessments in some applications  Regulatory Affairs Professionals Society | RAPS

Horizon Scanning - Visible - Swissmedic

Horizon Scanning - Visible  Swissmedic

"Significant health risk": Swissmedic warns of dangerous fake weight loss syringes | blue News - ...

"Significant health risk": Swissmedic warns of dangerous fake weight loss syringes | blue News  blue News

Switzerland Mutual Recognition Agreement - fda.gov

Switzerland Mutual Recognition Agreement  fda.gov

Swissmedic Accepts Marketing Authorization Application for Piflufolastat (18F) for Prostate Cance...

Swissmedic Accepts Marketing Authorization Application for Piflufolastat (18F) for Prostate Cancer  OncLive

Swissmedic Grants Good Manufacturing Practice Multi-Product License to Biogen Biologics Facility ...

Swissmedic Grants Good Manufacturing Practice Multi-Product License to Biogen Biologics Facility in Solothurn, Switzerland  Biogen

Counterfeit Ozempic diabetes medication in circulation - Swissmedic

Counterfeit Ozempic diabetes medication in circulation  Swissmedic

Swissmedic updates guidances on API, fast-track pathway, and more - Regulatory Affairs Profession...

Swissmedic updates guidances on API, fast-track pathway, and more  Regulatory Affairs Professionals Society | RAPS

Euro Roundup: Swissmedic revises four medicines authorization guidances - Regulatory Affairs Prof...

Euro Roundup: Swissmedic revises four medicines authorization guidances  Regulatory Affairs Professionals Society | RAPS

Swissmedic updates adverse event reporting requirements for 2024 - Regulatory Affairs Professiona...

Swissmedic updates adverse event reporting requirements for 2024  Regulatory Affairs Professionals Society | RAPS

Study: FDA more likely to approve drugs for broader populations than EMA, Swissmedic - Regulatory...

Study: FDA more likely to approve drugs for broader populations than EMA, Swissmedic  Regulatory Affairs Professionals Society | RAPS

KalVista Pharmaceuticals Announces European Commission and Swissmedic Approval of EKTERLY - Busin...

KalVista Pharmaceuticals Announces European Commission and Swissmedic Approval of EKTERLY  Business Wire

Kamada’s Glassia receives marketing approval from Swissmedic - Pharmaceutical Technology

Kamada’s Glassia receives marketing approval from Swissmedic  Pharmaceutical Technology

Euro Roundup: Swissmedic clarifies how foreign manufacturers can demonstrate GMP compliance - Reg...

Euro Roundup: Swissmedic clarifies how foreign manufacturers can demonstrate GMP compliance  Regulatory Affairs Professionals Society | RAPS

Swissmedic issues warning about the illegal medicinal product "Lemon Bottle" lipolysis solution -...

Swissmedic issues warning about the illegal medicinal product "Lemon Bottle" lipolysis solution  Swissmedic

Pfizer applies to Swissmedic for authorisation of another COVID-19 vaccine - Reuters

Pfizer applies to Swissmedic for authorisation of another COVID-19 vaccine  Reuters

Hemophilia B gene therapy Hemgenix approved in Switzerland - Hemophilia News Today

Hemophilia B gene therapy Hemgenix approved in Switzerland  Hemophilia News Today

Novartis gains Swissmedic nod for malaria treatment for infants - World Pharmaceutical Frontiers

Novartis gains Swissmedic nod for malaria treatment for infants  World Pharmaceutical Frontiers

No indication of risk due to COVID-19 booster shot bubbles -Swissmedic - Reuters

No indication of risk due to COVID-19 booster shot bubbles -Swissmedic  Reuters

Swissmedic approves J&J COVID-19 vaccine booster - Reuters

Swissmedic approves J&J COVID-19 vaccine booster  Reuters

Operation Pangea XVI: International campaign against falsified and illegally imported medicinal p...

Operation Pangea XVI: International campaign against falsified and illegally imported medicinal products  Swissmedic

Product groups without an intended medical purpose - Swissmedic

Product groups without an intended medical purpose  Swissmedic

Illegal imports 2021: Swissmedic seizes significantly more packages than in 2020 - Swissmedic

Illegal imports 2021: Swissmedic seizes significantly more packages than in 2020  Swissmedic

Landmark listing of first three countries as WHO-Listed regulatory Authorities - World Health Org...

Landmark listing of first three countries as WHO-Listed regulatory Authorities  World Health Organization (WHO)

“Revolving doors” with the pharmaceutical industry: a major source of influence on Swiss regulato...

“Revolving doors” with the pharmaceutical industry: a major source of influence on Swiss regulatory bodies?  Public Eye

Cannabis for medical purposes - Visible - Swissmedic

Cannabis for medical purposes - Visible  Swissmedic

Successful operation in control campaign against illegal trading in medicinal products - Swissmedic

Successful operation in control campaign against illegal trading in medicinal products  Swissmedic

Swissmedic participates in FDA Project Orbis - Swissmedic

Swissmedic participates in FDA Project Orbis  Swissmedic

CHUV introduces Switzerland's first gut-balancing medication - Greater Geneva Bern area

CHUV introduces Switzerland's first gut-balancing medication  Greater Geneva Bern area

Operation PANGEA XV: International campaign against falsified and illegally imported medicinal pr...

Operation PANGEA XV: International campaign against falsified and illegally imported medicinal products  Swissmedic

VMD and Swissmedic agree collaboration on veterinary medicinal products - GOV.UK

VMD and Swissmedic agree collaboration on veterinary medicinal products  GOV.UK

What does the name Swissmedic mean to you? - Swissmedic

What does the name Swissmedic mean to you?  Swissmedic

Swissmedic approves Novartis' new heart failure medicine Entresto(TM) - Novartis

Swissmedic approves Novartis' new heart failure medicine Entresto(TM)  Novartis

Meet René: The IDF’s First Ever Swiss-Bedouin Medic - idf.il

Meet René: The IDF’s First Ever Swiss-Bedouin Medic  idf.il

Aurinia Pharmaceuticals Announces Swissmedic Approval of LUPKYNIS® (voclosporin) - FinancialContent

Aurinia Pharmaceuticals Announces Swissmedic Approval of LUPKYNIS® (voclosporin)  FinancialContent

Report exposes widespread hygiene issues in Swiss hospitals - swissinfo.ch

Report exposes widespread hygiene issues in Swiss hospitals  swissinfo.ch

Side effects of COVID-19 vaccines in Switzerland – update - Swissmedic

Side effects of COVID-19 vaccines in Switzerland – update  Swissmedic

Committed to the next generation - Swissmedic

Committed to the next generation  Swissmedic

Swissmedic approves Kapruvia with additional regulatory decisions expected in H2 2022 - Indian Ph...

Swissmedic approves Kapruvia with additional regulatory decisions expected in H2 2022  Indian Pharma Post

Home Office vs. Office - Visible - Swissmedic

Home Office vs. Office - Visible  Swissmedic

Interview with Raimund Bruhin, Executive Director of Swissmedic - Swissmedic

Interview with Raimund Bruhin, Executive Director of Swissmedic  Swissmedic

Swissmedic approves Daiichi Sankyo's Lixiana - European Pharmaceutical Review

Swissmedic approves Daiichi Sankyo's Lixiana  European Pharmaceutical Review

The handbook of medicinal product quality - Swissmedic

The handbook of medicinal product quality  Swissmedic

Illegally imported medicinal products: underestimated risks! - Swissmedic

Illegally imported medicinal products: underestimated risks!  Swissmedic

Swiss regulator and media clash over weight-loss drugs - swissinfo.ch

Swiss regulator and media clash over weight-loss drugs  swissinfo.ch

Operation PANGEA XIV: campaign against counterfeit and illegally imported medicinal products - Sw...

Operation PANGEA XIV: campaign against counterfeit and illegally imported medicinal products  Swissmedic

Improving international collaboration – MHRA and Swissmedic sign MoU - GOV.UK

Improving international collaboration – MHRA and Swissmedic sign MoU  GOV.UK

Switzerland warns against using ‘Lemon Bottle’ fat-dissolving injections - swissinfo.ch

Switzerland warns against using ‘Lemon Bottle’ fat-dissolving injections  swissinfo.ch

The Shady Business Of Experimental Stem Cell Treatments - Worldcrunch

The Shady Business Of Experimental Stem Cell Treatments  Worldcrunch

Health: Swissmedic warns against dangerous weight loss products | blue News - blue News

Health: Swissmedic warns against dangerous weight loss products | blue News  blue News

Market surveillance - Visible - Swissmedic

Market surveillance - Visible  Swissmedic

Swissmedic approves Roche’s Ronapreve to treat COVID-19 patients - The Fiji Times

Swissmedic approves Roche’s Ronapreve to treat COVID-19 patients  The Fiji Times

Personalisierter Hirnstimulator bei Swissmedic registriert - Medinside

Personalisierter Hirnstimulator bei Swissmedic registriert  Medinside

Switzerland Clears First Malaria Medicine for Small Babies - Adda247

Switzerland Clears First Malaria Medicine for Small Babies  Adda247